title: [Diagnosis of the Paget-von Schroetter syndrome and monitoring of the therapeutic results (author's transl)].
abstract: Streptokinase or Urokinase can lead to complete healing in Paget-von Schroetter Syndrome. This tyne of lysis therapy should be instituted immediately or after the fourteenth postthrombotic day. The diagnosis should be verified by armphlebography. The therapeutic results must be controlled by phlebography in order to point out the need for continued therapy in case of thrombotic residual.
mesh_terms: D001367:Axillary Vein / Q000000981:diagnostic imaging*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011859:Radiography; D013300:Streptokinase / Q000627:therapeutic use; D013577:Syndrome; D013927:Thrombosis / Q000000981:diagnostic imaging* / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
vernacular_title: Diagnose und Therapiekontrolle des Paget-von-Schroetter-Syndroms.